Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation is a research paper published in Molecular Therapy — Oncolytics (2021). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI Cancer Moonshot
Grant: U01CA233085
NCI
Grant: U24 CA232979
NCI
Grant: R50 CA211108
NCI
Grant: P50CA159981
NCI
Grant: R03 CA223623
NCI
Grant: P30 CA016056
Merck
Grant: NCT02853318
NCI NIH HHS
Grant: P30 CA014599
National Institutes of Health
Grant: 1R03CA223623-01
The role of CREB3L1 in synergy between oncolytic vaccinia virus and doxorubicin
National Institutes of Health
Grant: 5R50CA211108-07
Associate-Director Flow and Image Cytometry Roswell Park ComprehensiveCancer Center
National Institutes of Health
Grant: 7U01CA233085-02
U01 Proposal Transfer - 2021
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 3U24CA232979-01S1
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
National Institutes of Health
Grant: 1P50CA159981-01A1
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
National Institutes of Health
Fields of Study
Keywords
Sustainable Development Goals